CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 37
- 13F valueReported value at the end of Q2 2026
- $5.42M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding CRVO, Q2 2026
No superinvestor reported holding CRVO at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by CervoMed Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Boger Joshua SDirector, 10% Owner | PPurchase | +955.4K | $3.14 | +$3.00M | +113.7%1.80M after | |
| Jun 15, 2026 (view filing) | Jun 11 | 4 days | Boger Joshua SDirector, 10% Owner | PPurchase | +1.91M | – | – | –955.4K after | Derivative2 lots |
| Nov 19, 2025 (view filing) | Nov 17-18 | 2 days | Winton MatthewChief Commercial and Business | PPurchase | +5.00K | $8.29 | +$41.4K | +50.0%15.0K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +10.8K | $8.46 | +$91.3K | +0.7%1.48M after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +10.8K | $8.46 | +$91.4K | +638.3%12.5K after | |
| Nov 19, 2025 (view filing) | Nov 17-18 | 2 days | Elder William RobertCFO, GC & Secretary | PPurchase | +3.50K | $8.36 | +$29.3K | +38.9%12.5K after | 2 lots |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Alam John JCEO & President | PPurchase | +10.8K | $8.46 | +$91.4K | +0.7%1.48M after | |
| Nov 19, 2025 (view filing) | Nov 17 | 2 days | Alam John JCEO & President | PPurchase | +10.8K | $8.46 | +$91.3K | +632.3%12.5K after | |
| Nov 17, 2025 (view filing) | Nov 13-14 | 4 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +6.15K | $7.53 | +$46.3K | +0.4%1.47M after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Gregoire SylvieDirector, 10% Owner | PPurchase | +1.69K | $7.55 | +$12.8K | New position1.69K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in CervoMed Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Woodline Partners LP | 688,987 | $2.14M | 0.01% | +688,987 | New |
| Vanguard Capital Management LLC | 316,202 | $980.2K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 248,880 | $771.5K | 6.42% | +248,880 | New |
| Geode Capital Management, LLC | 66,923 | $207.5K | 0.00% | −7,448−10.0% | Reduced |
| BlackRock, Inc. | 53,845 | $166.9K | 0.00% | +2,185+4.2% | Added |
| Byrne Asset Management LLC | 51,250 | $158.9K | 0.09% | +36,550+248.6% | Added |
| Citizens Financial Group Inc | 37,477 | $116.2K | 0.00% | 00.0% | Unchanged |
| Vanguard Fiduciary Trust Co | 36,151 | $112.1K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 32,231 | $99.9K | 0.00% | +13,985+76.6% | Added |
| Thompson Davis & Co., Inc. | 29,750 | $92.2K | 0.06% | +19,750+197.5% | Added |